Skip to main content
Wiley Open Access Collection logoLink to Wiley Open Access Collection
. 2022 Jul 7;11(17):2200075. doi: 10.1002/adhm.202200075

Noninvasive Stimulation of Peripheral Nerves using Temporally‐Interfering Electrical Fields

Boris Botzanowski 1, Mary J Donahue 2, Malin Silverå Ejneby 2, Alessandro L Gallina 3, Ibrahima Ngom 1, Florian Missey 1, Emma Acerbo 1, Donghak Byun 2, Romain Carron 1, Antonino M Cassarà 4, Esra Neufeld 4, Viktor Jirsa 1, Peder S Olofsson 3,5, Eric Daniel Głowacki 6,, Adam Williamson 1,3,
PMCID: PMC11468927  PMID: 35751364

Abstract

Electrical stimulation of peripheral nerves is a cornerstone of bioelectronic medicine. Effective ways to accomplish peripheral nerve stimulation (PNS) noninvasively without surgically implanted devices are enabling for fundamental research and clinical translation. Here, it is demonstrated how relatively high‐frequency sine‐wave carriers (3 kHz) emitted by two pairs of cutaneous electrodes can temporally interfere at deep peripheral nerve targets. The effective stimulation frequency is equal to the offset frequency (0.5 – 4 Hz) between the two carriers. This principle of temporal interference nerve stimulation (TINS) in vivo using the murine sciatic nerve model is validated. Effective actuation is delivered at significantly lower current amplitudes than standard transcutaneous electrical stimulation. Further, how flexible and conformable on‐skin multielectrode arrays can facilitate precise alignment of TINS onto a nerve is demonstrated. This method is simple, relying on the repurposing of existing clinically‐approved hardware. TINS opens the possibility of precise noninvasive stimulation with depth and efficiency previously impossible with transcutaneous techniques.

Keywords: bioelectronic medicines, electrical stimulation, flexible electronics, neurostimulation, temporal interference, transcutaneous


Efficient noninvasive nerve stimulation enables new solutions in bioelectronic medicine. The principle of interference stimulation using high‐frequency carriers delivered by flexible cutaneous electrode arrays is demonstrated. These are targeted to interfere constructively and stimulate peripheral nerve targets. This scalable method efficiently delivers electrical stimulation deep below the skin.

graphic file with name ADHM-11-2200075-g001.jpg

1. Introduction

Electrical stimulation of the nervous system is a powerful tool in fundamental biomedical research and is also at the center of bioelectronic medicine. Peripheral nerve stimulation (PNS) is at present one of the most extensive clinical fields of bioelectronic medicine, with the scope of new applications constantly growing.[ 1 , 2 , 3 ] Established examples of targets for PNS are the sacral, sciatic, and the vagus.[ 4 , 5 ] Vagus nerve stimulation is clinically approved for the treatment of certain types of epilepsy, and is in clinical trials for the treatment of chronic inflammatory conditions, depression, arthritis, obesity, and other examples.[ 6 , 7 , 8 , 9 , 10 , 11 ] Sacral nerve stimulation has been utilized since the 1970s and is used to treat various bowel and bladder dysfunctions.[ 12 ] Foot‐drop electrical therapy relies on stimulation of the nerves in the leg in order to treat foot drop, a condition where the feet “drag” and walking is difficult. Peripheral nerve stimulators are also used for treatment of various chronic pain disorders.[ 3 , 13 , 14 ] Presently, at both the level of fundamental research as well as clinical practice, PNS is relatively invasive. Implantation of stimulation electrodes, interconnects, and power supplies are necessary. Many of these techniques revolve around repurposing of well‐established implanted cardiostimulator technology. Though these procedures are highly optimized and constantly improving,[ 15 , 16 ] surgery inevitably involves risk and patient discomfort. This is particularly problematic as many protocols require regular surgical battery changes, and additional invasive surgery if patients elect to have stimulators removed. For this reason, less invasive (minimalistic devices) or completely noninvasive stimulation solutions are of great interest. If the target nerve is not too deep below the skin, currents delivered from cutaneous electrodes can accomplish stimulation. This principle is behind transcutaneous electrical nerve stimulation (TENS).[ 13 , 17 ] As a noninvasive solution, TENS procedures have been reported in numerous clinical studies, and commercial systems exist on the market. While very popular, the TENS approach has drawbacks. It is only applicable to shallow targets, and there are limits to the current magnitudes which can safely and comfortably be applied to the skin. Due to these limitations, as well as difficulty in precise targeting of nerves, widespread effective application of TENS has remained elusive, with the literature reporting mixed efficacy.[ 18 , 19 ] An alternative approach involves the use of focused ultrasonic waves, which can stimulate deeper targets than cutaneous electrical stimulation.[ 20 , 21 ] While promising, especially for central nervous system stimulation, for peripheral targets ultrasound has been less frequently used.[ 22 ] There is concern about the ultimate safety of relatively high‐power acoustic waves due to thermal and cavitation effects. Confounding effects from auditory stimulation via sound waves have also been reported as an obstacle. Alternative approaches based on transduction of near‐infrared light are promising, however require specialized equipment and are in an early stage of development.[ 23 , 24 , 25 ] The goal of effective noninvasive PNS remains an important unresolved issue in bioelectronic medicine.

In this work, we report a significantly more efficient transcutaneous electrical stimulation method – temporal interference nerve stimulation (TINS). This technique relies on two pairs of cutaneous electrodes driven by conventional clinical bipolar constant current stimulators. We exploit the principle of high‐frequency temporally‐interfering (TI) electric fields to stimulate deeper targets more efficiently than a typical topical nerve stimulator. The principle of “interferential therapy” was first postulated in 1959, and was used in a number of rehabilitation and sports medicine studies, with some influential reports from the former Soviet Union.[ 26 , 27 ] The idea of using so‐called “middle frequencies” in the 1–30 kHz range stems from the fact that skin has relatively low impedance in this region,[ 28 ] and therefore maximum current can be injected without causing pain when such frequencies are used in contrast to low‐frequency TENS.[ 29 ] This old idea of using this frequency window has recently been rediscovered and re‐evaluated in the context of modern bioelectronics and electrophysiology, starting with the work reporting TI as a promising noninvasive method for brain stimulation experiments in animal models by Grossman and coworkers in 2017.[ 30 ] Only a handful of work has followed up on this, and none with application to peripheral nerves.[ 31 , 32 ] TI stimulation relies on multiple high‐frequency electric fields that only cause neuronal activation where they constructively overlap. By controlling field orientation and frequency offset, the hot‐spot of constructive interference can be precisely targeted. The key aspect of this method is the use of carrier waves at frequencies higher than 1 kHz. Frequencies above this range are regarded as nonstimulating, and pass through tissues with relatively low loss. While these higher frequencies do not stimulate neural tissue, the interference envelope of two phase‐shifted frequencies can elicit action potentials because the offset (aka “beat”) frequency can be tuned accordingly to <100 Hz. A proposed theory is that low‐frequency envelopes stimulate neurons due to the nonlinear rectification of excitable cell membranes,[ 32 ] however the exact mechanism remains unclarified and a topic of debate.

Herein we test the TINS method on the mouse sciatic nerve, as this model allows rapid validation via observed muscle movement and electromyography (EMG) recording. TINS is applied via two pairs of surface electrodes driven by two clinical stimulators: one using a 3 kHz sine wave carrier frequency, and the other stimulator with frequency set to 3 kHz + n Hz offset (Figure  1A). We find that using the same electrodes and applying traditional TENS does not evoke a PNS response for the same amplitude of stimulation used with TINS. This corresponds well with finite element modeling of the electric field distribution, which demonstrates how TINS focuses electrical stimulation much deeper than TENS (Figure 1A). Having proved the efficacy of our approach using standard electrode pins, we next fabricated flexible multielectrode arrays (fMEAs). The fMEAs conform to the skin and have a grid of 40 addressable electrodes (Figure S1, Supporting Information) which allow for selecting a combination of electrode pairs that optimally directs TINS to the peripheral nerve target (Figure 1B).

Figure 1.

Figure 1

Temporal Interference Nerve Stimulation, TINS. The mouse sciatic nerve is used as a model PNS target, allowing both limb movement and EMG as read‐outs. A) Left: TINS utilizes two pairs of electrodes driven at high frequency (3 kHz), with a frequency offset n = Δf. The n becomes the interference envelope beat frequency which accomplishes stimulation at the hot spot where the two electric fields interfere (middle, bottom). TINS allows reaching targets deeper below the skin than transcutaneous electrical nerve stimulation TENS (middle, top). Right: The calculated difference between TENS and TINS using finite element modeling of the electric field distribution on a cylindrical body. TENS generates the highest electric field in the immediate vicinity of the surface, while TINS with two electrode pairs results in a deeper focus of the electric field and the field near the surface of the cylinder is minimal. B) Stimulation electrode comparison: We first evoke PNS responses noninvasively using TINS from standard surface electrodes which are placed on the skin and positioned using a stereotaxic arm (leftmost image). To optimize alignment without needing any mechanical manipulation, we developed a flexible multielectrode array, fMEA, (4 µm‐thick) with 40 conducting polymer‐coated electrodes which conform to the skin. Right: With the fMEA, optimal stimulation alignment can be accomplished using electronics alone.

2. Results and Discussion

The first experimental goal was validating that TINS can work to stimulate the sciatic nerve. Experiments were performed using two clinically‐approved bipolar constant‐current stimulators (Digitimer DS5), modulating two separate pairs of electrodes. As stimulating electrodes, we initially utilized point electrodes in the form of gold pins (0.63 mm diameter), with a distance of 2.54 mm between each electrode (center to center), as shown in Figure 1. Using a current of 350 µA with 3 kHz sine carriers and frequency offsets of 0.5 Hz – 4 Hz, we observed clear and regular muscle contractions and leg movements at intervals corresponding to the envelope frequency (Figure  2 , and Supplementary Video S1, Supporting Information). This evidences that motor fibers within the sciatic nerve are activated. As controls, a 3002 Hz sine wave stimulation and a classical 2 Hz TENS stimulation with two electrodes were attempted and no PNS effect was observed using a current of 500 µA (Figure S2, Supporting Information). Clear muscle movement was not evoked with TENS until >1 mA was applied.

Figure 2.

Figure 2

TINS evokes responses at the envelope frequency. Carrier frequencies of 3000 Hz and 3000 + n Hz (350 µA) are applied non‐invasively to gold pin electrodes above the sciatic nerve. n is increased from 0.5 Hz to 4 Hz and the PNS kicking response follows the increase in envelope frequency. The video of this experiment is available in the supportingl information. In the bottom panel, the kicking frequency is matching the offbeat frequency of the envelope when the frequency of the second pair is changed dynamically. n = 4 mice per group, all mice respond similarly however for clarity only data from 1 mouse is plotted in the bottom panel.

The TINS method was effective as shown in Figure 2, however, the electrodes had to be carefully landmarked and aligned manually in order to overlap the interference hot spot onto the sciatic nerve. To overcome the necessity of having to position the stimulation electrodes manually by manipulating a stereotactic arm, we fabricated a fMEA with a grid of 40 electrodes (5 × 8 electrodes, diameter 500 µm, spacing 1.25 mm between each electrode center to center), as shown in Figure 1B. The fMEAs are conformable grids that can be positioned roughly over the area where PNS is desired, and then pairs of electrodes can be cycled electronically to optimize targeting (Figure  3 ). In our work, once a column of electrodes was identified to evoke a response, it was seen that the next column of electrodes in the perpendicular direction did not evoke a response when tested, see Figure S3, Supporting Information. This is likely due to the limited pitch between electrode (1.25 mm for grids and stereotactically approximately 1 mm for the larger pins). Parallel electrode selections, in this specific nerve application, do not highlight the advantage of the ability to move in the parallel direction is as the sciatic nerve is generally long compared to the grid or pin holder. A smaller nerve with sharper turns will highlight the additional directional control. The alignment of the stimulation was done by scanning TINS over different electrodes while recording EMG signals and monitoring motor movement with video. It should be noted that combinations of various electrodes allow the TINS to not only scan laterally to modify the xy position of stimulation hot‐spot, but also vertically to reach deeper or shallower nerve targets. As seen in Figure 3A, alignment in this application utilizes video detection of the TINS evoked kick and a measured compound muscle action potentials (CMAPs). The effects of alignment can likewise be visualized in Figure 3A and by finite element modeling in Figure  4 . The CMAP signal is the sum of numerous simultaneous action potentials from muscle fibers activated via a nerve, in this case, the sciatic nerve. When an optimal alignment is detected, a CMAP is visible on the recorded signal or a vigorous kick is observed, the scan stops. Further parameters, for example, the envelope frequency or stimulation amplitude, can then be studied on the nerve of interest. Using CMAP recording to tune TINS is enabled by the fact that the TINS stimulation artefacts are present at a significantly higher frequency range than the electrophysiological signal of interest. The power spectral density (PSD) only contains the two carrier frequencies and no low‐frequency content, as it is the superimposed sum of two high‐frequency oscillations (Figure 3B). Therefore, when performing electrophysiological recordings, it is trivial to apply a filter to the high‐frequency stimulation artefacts, thus obtaining the biologically relevant signal.

Figure 3.

Figure 3

Self‐alignment of TINS to deep peripheral nerves using scannable fMEAs. A) A Compound muscle action potential (CMAP) response is evoked and recorded synchronously with the leg kick. The scannable fMEA grid allows alignment to be automated, reducing the time required to locate the nerve. B) TINS creates electrical artifacts at much higher frequencies than the biological signal of interest. The raw electrical artifact of a TI signal contains only peaks at the carrier frequency, the envelope frequency does not appear in the PSD. (Left panel) The two pairs of electrodes on the mouse's thigh, therefore, create only f1 + f2, not the envelope frequency and not other combinations of f1 and f2. Any other signals are thus from other sources, such as the electrophysiological activity of biological tissue (Middle panel) In PNS stimulation we selected sufficiently high carrier frequencies to be far away from the biological signal of interest. (Right panel) We see the resulting filtered PSD, leaving only the biological signal of interest. This phenomenon allows excellent recordings of events during stimulation and opens numerous opportunities for closed‐loop phase‐locking applications in PNS and prosthetics.

Figure 4.

Figure 4

Simulation of electrode configurations and electric field at the nerve. The selected configuration in a row of electrodes, and the selected row parallel to the nerve of interest, strongly impacts the magnitude and profile of the amplitude modulation at the depth of the nerve. A) Schematic representation of the simplified simulation setup used to compare different stimulation strategies. It features a multi‐fascicular nerve model at a depth of 7 mm within muscle tissue and a range of electrode contacts. B) TI modulation envelope magnitude of the axon‐aligned field component according to Equation 2 for different electrode configurations of the two electrode pairs (1 mA input current per pair, i.e., 2 mA in total with a current ratio of 1:1); nested (C0, electrode pairs 1–12, 4–8), adjacent (C1, electrode pairs 1–6, 7–12), interleaved (C2, electrode pairs 1–8, 4–12), adjacent with varying separation distances (C3, electrode pairs 1–5, 7–12; C4, electrode pairs 1–4, 8–12; C5 electrode pairs 1–3, 9–12). Electrode diameter 500 µm, C) Selection of a row of electrodes off‐axis with respect to the nerve, as seen in the full simulation, rapidly reduces the TI‐exposure of the nerve.

The TI field distribution for a range of electrode configurations was simulated to assess focality and nerve exposure amplitude assessed using computational modeling, comparing nested, interleaved, and adjacent (with varying distance) electrode pairs (Figure 4). Based on these calculations, it can be said that TI provides a much better balance between nerve stimulation and stimulation of overlaying tissues (by one order of magnitude). While a configuration with opposed electrode pairs could fully eliminate surface TI hot spots, it was not suitable for anatomical access limitations. All the other simulated configurations produce surface hot spots where the fields from neighboring electrodes of different pairs are oriented parallelly. The TI magnitude at depth (according to Equations 1 and 2) is highest for the nested and the interleaved configurations (which are also the least focal ones). For these configurations, the TI magnitude is comparable to the carrier magnitude (again because of the parallelity), while it drops to 20% for the most separated variant of the adjacent configurations. At the same time, the TI modulation magnitude at the surface can be more than one order of magnitude smaller than that of the carrier field. The adjacent one with the smallest separation distance is the most focal one, but also produces the strongest surface TI exposure; surface exposure quickly diminishes with increasing separation, while focality is maintained. When considering the strong preferential axon orientation in nerves and evaluating the TI modulation amplitude exclusively along the nerve direction, the efficiency of the adjacent configurations is strongly reduced (up to a factor >2) compared to the nested and interleaved ones, where currents are better aligned with the nerve in their intersection region. Figure 4 also illustrates the impact of the fascicular nerve structure, with its semi‐insulating epineurium on exposure strength. The perineurium, combined with the anisotropic fascicular conductivity, result in a longitudinal smoothing, but also an overall reduction, of the intrafascicular fields. In summary, when it is not possible to place the second electrode pair on the opposing side for anatomical reasons (too distant), the nested configuration is preferable in terms of stimulation effectivity and surface exposure reduction when focality does not matter, while the adjacent configurations (at an optimized separation distance) are preferable otherwise.

3. Conclusions

The tradeoff of non‐invasiveness versus specificity is an accepted limitation in the field of electrical stimulation of the nervous system. Highly selective stimulation at anatomic depth usually requires invasive, implanted electrodes.[ 5 ] Non‐invasive treatments, meanwhile, necessarily sacrifice specificity. The main motivation of our work has been overcoming this fundamental obstacle. The TINS method we have tested, which relies on safe transmission of high‐frequency signals through the tissue and subsequent constructive interference at the stimulation area of interest, can indeed solve this problem. The use of a carrier frequency of 3000 Hz exploits the fact that skin has relatively low impedance at this frequency, and therefore more current can be injected without reaching pain thresholds in the skin, a major advantage over conventional low‐frequency TENS. Our data validates efficacy of stimulation of the sciatic nerve, under conditions where normal transcutaneous stimulation, TENS, could not elicit any response. The TINS method is supported by modeling and calculation, and relies on relatively well‐established principles in electrodynamics. Furthermore, TINS can be performed using existing hardware, provided proper channel isolation and very good linearity are ensured, which makes adoption in animal research and potential clinical translation facile. The geometry of the electrode pairs used in TINS dictates where the stimulation hot spot will be. To facilitate precise nerve targeting, we have demonstrated the use of soft, flexible, and conformable cutaneous multielectrode arrays which can be positioned roughly over the area of interest. Scanning of different permutations of electrode pairs can then be done automatically, while performing a readout of desired stimulation effects. This procedure is made more powerful by the fact that the stimulation artefacts produced by TINS are exclusively in a high‐frequency range ≥(3 kHz), allowing filtering to be used to isolate electrophysiological signals of interest. TINS allows noninvasive stimulation experiments to be performed using experimental animal models, thus enabling large‐scale neuromodulation experiments that were previously extremely laborious or impossible. TINS can be used in the clinic to deliver acute therapy to PNS targets. We envision TINS as a useful clinical procedure for benchmarking the efficacy of electrical stimulation in patients who are candidates for an implantable technology. TINS can allow clinicians to test and titrate stimulation parameters to determine if patients are good candidates for a more invasive and permanent therapeutic bioelectronic intervention. Finally, besides these examples of acute applications, advances in the technology of conformable cutaneous electrodes[ 33 , 34 ] can allow TINS to be applied chronically in bioelectronic medicine applications. To this end, our work also shows the potential for ultrathin cutaneous electrode arrays based on plastic foils and conducting polymer electrodes. These arrays are extremely lightweight and conformable. Future research to expand the possibilities with TINS can feature using more than two electrode pairs to further focus the stimulation hot‐spot.

4. Experimental Section

Animal Procedures

This study and all experimental protocols were approved by the Stockholm Regional Board for Animal Ethics (Stockholm, Sweden) (approval number N104/16). Four mice were used in these experiments.

Fabrication of Flexible Multielectrode Arrays

The flexible, “self‐aligning” electrode grid fabrication process is based on previously reported methods.[ 35 , 36 ] First, a parylene‐C (PaC) film was deposited on clean glass wafers using a chemical vapor deposition system (Diener GmbH), resulting in a thickness of 2.5 µm. No adhesion promoter is used as this PaC layer is delaminated from the glass after all fabrication steps are complete and acts as the final underlying substrate. Photolithography and lift‐off processes were employed to pattern metal interconnects on top of the PaC substrate. This was performed using a negative lift‐off photoresist (nLof 2070), a SUSS MA 6 UV broadband contact aligner, and AZ MIF 729 developer. After development, an O2 plasma treatment is carried out and a 2 nm chromium adhesion promoting layer and 100 nm of gold were then thermally evaporated onto the substrates. The samples were immersed in an acetone bath to complete the liftoff process and define the interconnects. To electrically insulate the metal lines, a second parylene‐C (PaC) film was deposited on the devices to thicknesses of 2 µm, using the same deposition process as before, however with 3‐(Trimethoxysilyl)propylmethacrylate present in the chamber to act as an adhesion promoter. Subsequently, an etch mask is patterned using the positive photoresist AZ 10XT patterned with the UV contact aligner and AZ developer. This is used to define the outline/shape of the overall device and the PaC is etched through reactive ion etching (RIE) with an O2/CF4 plasma. Following this etch and subsequent removal of the photoresist, a dilute solution of Micro‐90 industrial cleaner was spin‐coated onto the insulation layer, followed by the deposition of a sacrificial PaC layer (2 µm). These steps allow the sacrificial layer to later be peeled from the substrate, defining PEDOT:PSS at the electrode sites. The sacrificial PaC layer was etched as before, using RIE after an AZ 10XT mask was patterned to open the electrode sites and back contacts by creating an opening down to the gold interconnects. A dispersion of PEDOT:PSS (CleviosTM PH 1000 from Heraeus Holding GmbH), 5 volume % ethylene glycol, 0.1 volume % dodecyl benzene sulfonic acid, and 1 wt % of (3‐glycidyloxypropyl)‐trimethoxysilane was spin coated onto the substrates. Multiple layers were coated to attain a thickness of ≈1.5 µm allowing good skin contact of the final device without the use of electrolyte. Between each coating process, short baking steps were used (1 min, 90 °C) and the substrates were allowed to cool to room temperature. The sacrificial PaC layer was peeled off removing superfluous PEDOT:PSS and defining the electrode sites. The devices were baked for 1 h at 140 °C to crosslink the film. Finally, the devices were immersed in deionized water to remove low molecular weight compounds. This water soak also facilitates the delamination of the final flexible electrode array from the glass wafer.

To make electrical contact to the flexible devices, the backside was laminated onto a Kapton film. This was placed into a zero insertion force clip (ZIF‐Clip) soldered onto an adapter printed circuit board. This board allowed for simple wired connection to a current source.

Recording of CMAPs in the Mouse Leg

Measurements were obtained using a 27G stainless steel recording needle implanted in the tibialis anterior muscle and a reference needle implanted in the skin above the extensor digitorum longus muscle. Both needle shafts were passivated with insulating plastic, with only 2 mm remained uninsulated at the tip. Both electrodes were connected to an RHS Stim/Recording System from Intan technologies through a 16‐channel RHS headstage. Recordings were captured with a 50 Hz notch filter.

Leg Movement Analysis

During the stimulations, mice were filmed with an high angle shot at 30 frames per second. The mp4 files created were then imported to ImageJ 1.53q using to the plugin FFMPEG. The position of the tip of the mouse was then tracked with the Manual Tracking plugin. Pixels were scaled in mm thanks to a reference in the video. The movement was plotted over time with MATLAB (Mathworks) R2020B. For Figure 2, upper and lower envelopes were added for clarity. For Figure S2, Supporting Information, a lowpass filter function of 8 Hz was used to highlight the movement.

Mouse Preparation

Mice were anesthetized with isoflurane gas, a concentration of 3% was used to induce anesthesia and a concentration around 1.5% – 2% was used to maintain the anesthetized condition. Mice were then placed slightly on the side to allow a comfortable access to the leg. The mouse position was secured utilizing cushions of gauze under their belly and neck. The mouse temperature was monitored at 37 °C and maintained through a Homeothermic System from AgnThos. Hair Removal Cream from veet was used to remove fur on the leg and then gently rinsed with water.

Temporal Interference Electrical Stimulation, TINS, of the Sciatic Nerve

Temporal interference stimulation of sciatic nerve was done using a 4‐pin gold‐plated contacts header from Farnell (ref. 825433–4), each of the contacts is separated by a center‐to‐center distance of 2.54 mm. The pin header was placed above the sciatic nerve with the 4 contacts touching the skin. Special care was made to ensure that the pin header was aligned with the sciatic nerve, when the position of the header seemed to be ideal, it was maintained thanks to a third hand soldering helper. If stimulation turned out to be ineffective, the pin header was repositioned until the stimulation drove a muscular response. Stimulation parameters were provided by a two‐part system: Waveforms (frequency and waveshape components) were provided by a function generator Keysight EDU33212A and current amplitude was controlled by a DS5 isolated bipolar constant current stimulator from Digitimer. Each pair (the stimulator and its ground) of electrode was connected to its own DS5, itself connected to its independent function generator.

TINS of the sciatic nerve was also done using a conforming grid of conducting polymer electrodes. Once the grid was placed on the leg mouse it was possible to stimulate through any of the 40 contacts composing the grid. This allowed the manipulator to dynamically select different spatial configurations and eliminated the need to reposition the grid if stimulations were ineffective. Stimulation parameters were provided in the same fashion as with the pin header.

Control Stimulations

Once the location of the stimulators and amplitude threshold were attained to induce a kicking with the TINS stimulation (500µA in the TINS control experiment), classical TENS (2 Hz) and the stimulation with a single frequency carrier (3002 Hz) were performed at the same amplitude (500 Hz) and location as the PNS inducing TINS.

Signal Treatment

Signals were recorded in .rhs format and converted in .mat then analyzed with MATLAB (Mathworks) R2020B. Signals were lowpass‐filtered at 800 Hz to remove the high‐frequency stimulation artefact. All signals were aligned to the positive maximum of their CMAP before any statistical calculation. 25 typical CMAP have been extracted and the average response has been plotted along its calculated interquartile area. The average, the 25th percentile and the 75th percentile of these signals have been calculated and plotted with MATLAB (Mathworks) R2020B. The interquartile area is displayed in light blue in Figure 3A.

Finite Element Modeling

Finite element model simulations were done with COMSOL Multiphysics 5.5 for Figure 1 and Sim4life v6.2.1.4972 (ZMT Zurich MedTech AG, Zurich, Switzerland) for Figure 4. Both, simplified (more controlled) and anatomically detailed (more realistic) modeling was performed. The former features a 2.5 dimensional nerve model, generated by linearly extruding a manually segmented histological cross‐section image of a rat sciatic nerve, embedded at 7 mm depth in a homogeneous volume conductor filled with muscle tissue (σ axial = 0.33 S m−1). The latter involves the anatomically detailed “Neurorat” rodent model (obtained by segmenting MRI and CT image data from a 150 g and 150 mm long (without tail) Dark Agouti rat[ 37 ] in which a nerve model was embedded by extruding the same cross‐section used in the simplified model along the model‐provided sciatic nerve trajectory. Dielectric properties were assigned according to the low‐frequency dielectric tissue parameters from the IT'IS tissue properties database and the predefined tissue assignment tags in the NEUROFAUNA model. Nerve properties were treated as anisotropic within the fascicles (i.e., differing longitudinal and transversal conductivities; σ radial = 0.087 S m−1 and σ axial = 0.57 S m−1). Epineurium and fascicle perineurium were treated as thin, highly‐resistive layers, with σ memb = 0.00087 S m−1 and thicknesses assigned as 3% of the fascicle/nerve diameter according to ref.[38] Electric fields for the electrode pairs of interest were simulated using the ohmic‐current dominated electroquasistatic solver family in Sim4Life, which solves the equation ∇σϕ = 0 – a valid approximation of Maxwell's equation[ 39 ] when the wavelength is large compared to the simulation domain and displacement currents are negligible compared to resistive ones (these conditions were verified for the given setups). Electrodes were modeled as cylinders sized and placed in accordance to the experiments and to the investigated scenarios from Figure 4. Dirichlet boundary conditions were used before normalizing the input currents to 1 mA per pair (resulting in a total input current of 2 mA), as they provide superior predictions of current distributions near electrodes compared to flux boundary conditions. Convergence analyses were performed to ensure that the resolution and solver tolerances are suitable. The built‐in Sim4Life functionality was used to compute the TI exposure metric according to:[ 1 ]

EAMmax(r)=2E2rifE2r<E1rcosα,otherwiseEAMmax(r)=2E2r×E1rE2rE1rE2r (1)

which is the maximum of the modulation envelope magnitude along any spatial orientation (assuming without loss of generality that α < π/2 and |E2(r)|<|E1(r)|). When there is a dominant neural orientation (e.g., axons in nerve), the modulation magnitude of the field component along that direction is used as TI exposure metric instead:

|EAM(r,d)|=2min(|E1(r)·d|,|E2(r)·d|) (2)

Simulations on the anatomical model were executed using the structured variant of the ohmic current dominated low‐frequency solver (≈110 Miovoxs, 0.08–0.25 mm resolution). The simulations on the simplified model were performed using the unstructured solver variant of the low frequency (40 Mio tetrahedral, pyramidal, and prismatic elements), which is numerically less robust, but provides the thin resistive layer model used to model the perineurium and the epineurium.

For the COMSOL simulation in Figure 1, a cylinder mesh of 10 mm in diameter and 20 mm in length was designed to represent a portion of a mouse leg. Each electrode interface with the mouse was defined by a disk of 0.63 mm. Dielectric properties for muscle tissue at 3 kHz, the permittivity of 9.79E + 4, and electrical conductivity of 3.33E‐1 S m−1 were applied to the grid model. The physics interface chosen for the simulation was Electrical Currents Interface solver with this equation: ∇.J  = Q j.v , where J=σE+Dt+JE and E  =   − ∇V. The study node selected was time‐dependent. All plots were directly obtained via the built‐in tools of COMSOL Multiphysics 5.5.

Conflict of Interest

P.S.O.; E.D.G.; and A.W. are coinventors on a patent application covering the TINS method. P.S.O. is a shareholder in Emune AB. E.N. is a shareholder and board member of TI Solutions AG.

Author Contributions

E.D.G. and A.W. contributed equally to this work. B.B. and M.J.D performed experiments. M.J.D and D.B. designed and fabricated flexible cutaneous multielectrode arrays. B.B., M.J.D., A.L.G., M.S.E., F.M., and E.A. all performed in vivo stimulation and recording experiments and analyzed data. B.B., I.N., A.M.C, and E.N did the finite‐element simulations and analysis. A.W., E.D.G., M.J.D and B.B., wrote the paper with input from all other authors. P.S.O., E.D.G., and A.W supervised the project.

Supporting information

Supporting Information

Supplemental Video 1

Download video file (13MB, mp4)

Acknowledgements

This project has received funding from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program (A.W. grant agreement No. 716867; E.D.G. grant agreement No. 949191). E.D.G. acknowledges funding from the City Council of Brno, Czech Republic. M.J.D acknowledges funding from the European Research Council (834677 “e‐NeuroPharma” ERC‐2018‐ADG). P.S.O. and A.L.G. were funded by MedTechLabs and the Swedish Research Council.

Botzanowski B., Donahue M. J., Ejneby M. S., Gallina A. L., Ngom I., Missey F., Acerbo E., Byun D., Carron R., Cassarà A. M., Neufeld E., Jirsa V., Olofsson P. S., Głowacki E. D., Williamson A., Noninvasive Stimulation of Peripheral Nerves using Temporally‐Interfering Electrical Fields. Adv. Healthcare Mater. 2022, 11, 2200075. 10.1002/adhm.202200075

Contributor Information

Eric Daniel Głowacki, Email: eric.daniel.glowacki@ceitec.vutbr.cz.

Adam Williamson, Email: adam.williamson@ki.se, Email: adam.williamson@univ-amu.fr.

Data Availability Statement

The data that support the findings of this study are available in the supplementary material of this article.

References

  • 1. Krames E. S., Peckham P. H., Rezai A. R., Eds., Neuromodulation, Academic Press, London: 2009. [Google Scholar]
  • 2. Birmingham K., Gradinaru V., Anikeeva P., Grill W. M., Pikov V., Mclaughlin B., Pasricha P., Weber D., Ludwig K., Nat. Rev. Drug Discovery 2014, 13, 399. [DOI] [PubMed] [Google Scholar]
  • 3. Horch K., Kipke D., Eds., Neuroprostetics: Theory and Practice, World Scientific, Singapore: 2017. [Google Scholar]
  • 4. Olofsson P. S., Tracey K. J., J. Intern. Med. 2017, 282, 3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Larson C. E., Meng E., J. Neurosci. Methods 2020, 332, 108523. [DOI] [PubMed] [Google Scholar]
  • 6. Johnson R. L., Wilson C. G., J. Inflammation Res. 2018, 11, 203. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Ben‐Menachem E., Revesz D., Simon B. J., Silberstein S., Eur. J. Neurol. 2015, 22, 1260. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8. Ben‐Menachem E., Hellström K., Waldton C., Augustinsson L. E., Neurology 1999, 52, 1265. [DOI] [PubMed] [Google Scholar]
  • 9. Bonaz B., Sinniger V., Hoffmann D., Clarençon D., Mathieu N., Dantzer C., Vercueil L., Picq C., Trocmé C., Faure P., Cracowski J. L., Pellissier S., Neurogastroenterol. Motil. 2016, 28, 948. [DOI] [PubMed] [Google Scholar]
  • 10. Bottomley J. M., LeReun C., Diamantopoulos A., Mitchell S., Gaynes B. N., Compr. Psychiatry 2020, 98, 152156. [DOI] [PubMed] [Google Scholar]
  • 11. Dawson J., Liu C. Y., Francisco G. E., Cramer S. C., Wolf S. L., Dixit A., Alexander J., Ali R., Brown B. L., Feng W., DeMark L., Hochberg L. R., Kautz S. A., Majid A., O'Dell M. W., Pierce D., Prudente C. N., Redgrave J., Turner D. L., Engineer N. D., Kimberley T. J., Lancet 2021, 397, 1545. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Grill W. M., Kirsch R. F., Assist. Technol. 2000, 12, 6. [DOI] [PubMed] [Google Scholar]
  • 13. DeSantana J. M., Walsh D. M., Vance C., Rakel B. A., Sluka K. A., Curr. Rheumatol. Rep. 2008, 10, 492. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Perryman L. T., Am. J. Anesth. Clin. Res. 2018, 4, 19. [Google Scholar]
  • 15. Otchy T. M., Michas C., Lee B., Gopalan K., Nerurkar V., Gleick J., Semu D., Darkwa L., Holinski B. J., Chew D. J., White A. E., Gardner T. J., Nat. Commun. 2020, 11, 4191. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. Choi Y. S., Hsueh Y. Y., Koo J., Yang Q., Avila R., Hu B., Xie Z., Lee G., Ning Z., Liu C., Xu Y., Lee Y. J., Zhao W., Fang J., Deng Y., Lee S. M., Vázquez‐Guardado A., Stepien I., Yan Y., Song J. W., Haney C., Oh Y. S., Liu W., Yun H. J., Banks A., MacEwan M. R., Ameer G. A., Ray W. Z., Huang Y., Xie T., et al., Nat. Commun. 2020, 11, 5990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. Ottestad E., Orlovich D. S., Pain Med. (United States) 2020, 21, S3. [DOI] [PubMed] [Google Scholar]
  • 18. Robinson K., Platt S., Stewart G., Reno L., Barber R., Boozer L., Front. Vet. Sci. 2020, 7, 569739. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. Gibson W., Wand B. M., Meads C., Catley M. J., O'connell N. E., Cochrane Database Syst. Rev. 2019, 2019, CD011890. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. Blackmore J., Shrivastava S., Sallet J., Butler C. R., Cleveland R. O., Ultrasound Med. Biol. 2019, 45, 1509. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21. Di Biase L., Falato E., Di Lazzaro V., Front. Neurol. 2019, 10, 549. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. Cotero V., Fan Y., Tsaava T., Kressel A. M., Hancu I., Fitzgerald P., Wallace K., Kaanumalle S., Graf J., Rigby W., Kao T. J., Roberts J., Bhushan C., Joel S., Coleman T. R., Zanos S., Tracey K. J., Ashe J., Chavan S. S., Puleo C., Nat. Commun. 2019, 10, 952. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23. Jiang Y., Carvalho‐de‐Souza J. L., Wong R. C. S., Luo Z., Isheim D., Zuo X., Nicholls A. W., Jung I. W., Yue J., Liu D.‐J., Wang Y., De Andrade V., Xiao X., Navrazhnykh L., Weiss D. E., Wu X., Seidman D. N., Bezanilla F., Tian B., Nat. Mater. 2016, 15, 1023. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. Ejneby M. S., Jakešová M., Ferrero J. J., Migliaccio L., Sahalianov I., Zhao Z., Berggren M., Khodagholy D., Đerek V., Gelinas J. N., Głowacki E. D., Nat. Biomed. Eng. 2022, 6, 741. [DOI] [PubMed] [Google Scholar]
  • 25. Ferlauto L., Jole M., Airaghi I., Aurelia N., Chenais L., Charles S., Gilliéron A., Vagni P., Bevilacqua M., Wolfensberger T. J., Sivula K., Ghezzi D., Nat. Commun. 2018, 9, 992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26. Stone J. A., Athl. Ther. Today 1997, 2, 1019. [Google Scholar]
  • 27. Ward A. R., Phys. Ther. 2009, 89, 181.19095805 [Google Scholar]
  • 28. Rosell J., Colominas J., Webster J. G., IEEE Trans. Biomed. Eng. 1988, 35, 649. [DOI] [PubMed] [Google Scholar]
  • 29. Ward A. R., Robertson V. J., Makowski R. J., Arch. Phys. Med. Rehabil. 2002, 83, 1024. [DOI] [PubMed] [Google Scholar]
  • 30. Grossman N., Bono D., Dedic N., Kodandaramaiah S. B., Rudenko A., Suk H. J., Cassara A. M., Neufeld E., Kuster N., Tsai L. H., Pascual‐Leone A., Boyden E. S., Cell 2017, 169, 1029. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31. Missey F., Rusina E., Acerbo E., Botzanowski B., Front. Neurosci. 2021, 15, 633988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32. Mirzakhalili E., Barra B., Capogrosso M., Lempka S. F., Cell Syst. 2020, 11, 557. [DOI] [PubMed] [Google Scholar]
  • 33. Vėbraitė I., Hanein Y., Front. Med. Technol. 2021, 3, 675744. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34. Bauer S., Bauer‐Gogonea S., Graz I., Kaltenbrunner M., Keplinger C., Schwödiauer R., Adv. Mater. 2014, 26, 149. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35. Sessolo M., Khodagholy D., Rivnay J., Maddalena F., Gleyzes M., Steidl E., Buisson B., Malliaras G. G., Adv. Mater. 2013, 25, 2135. [DOI] [PubMed] [Google Scholar]
  • 36. Donahue M. J., Kaszas A., Turi G. F., Rózsa B., Slézia A., Vanzetta I., Katona G., Bernard C., Malliaras G. G., Williamson A., eNeuro 2018, 5, ENEURO.0187. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37. https://itis.swiss/virtual‐population/animal‐models/animals/ (accessed: December 2021).
  • 38. Grinberg Y., Schiefer M. A., Tyler D. J., Gustafson K. J., IEEE Trans. Neural Syst. Rehabil. Eng. 2008, 16, 572. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39. Bossetti C. A., Birdno M. J., Grill W. M., J. Neural Eng. 2008, 5, 44. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supporting Information

Supplemental Video 1

Download video file (13MB, mp4)

Data Availability Statement

The data that support the findings of this study are available in the supplementary material of this article.


Articles from Advanced Healthcare Materials are provided here courtesy of Wiley

RESOURCES